AS
Publicaties op Oncologisch.com
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-...
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer.
Ipilimumab-FOLFOX versus nivolumab-trastuzumab bij HER2-positief gastro-oesofageaal carcinoom
Perioperatieve capecitabine met of zonder oxaliplatine bij rectumcarcinoom: PETACC-6 fase III